Literature DB >> 3143315

Immune complexes and Pseudomonas aeruginosa antibodies in cystic fibrosis.

H P Van Bever1, P L Gigase, L S De Clerck, C H Bridts, H Franckx, W J Stevens.   

Abstract

Serum samples from 57 patients with cystic fibrosis were tested for the presence of IgG, IgA, IgM, IgE, and circulating immune complexes containing IgG, IgA, and IgM. Titres of class specific antibodies to Pseudomonas aeruginosa, and class specific antibodies to Ps aeruginosa in circulating immune complexes, were also measured. According to the Shwachman score the patients were divided into three clinical groups: group 1-moderate and severe disease, group 2-mild disease, and group 3-well. The results of the immunological investigations were correlated with the clinical state of the patients as assessed by the Shwachman score. Serum concentrations of IgG, IgA, and IgM were inversely correlated with the Shwachman score, but the differences between the groups were only significant for IgG and IgA. The same correlations were found for circulating immune complexes containing IgG and IgA. Antibodies to Ps aeruginosa could be detected in most of the patients' serum samples. IgA antibody specific to Ps aeruginosa was the most often raised, even in patients in group 3. It is therefore suggested that IgA antibody specific to Ps aeruginosa could be an early marker of colonisation by Ps aeruginosa and a sensitive measurement of infection with Ps aeruginosa in young children with cystic fibrosis. Moreover, in the circulating immune complexes, class specific antibodies to Ps aeruginosa were found in nearly half the patients. The highest titres of IgG and IgA antibodies specific to Ps aeruginosa in the circulating immune complexes were detected in the patients with the worst clinical state (group 1).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3143315      PMCID: PMC1779004          DOI: 10.1136/adc.63.10.1222

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period.

Authors:  H SHWACHMAN; L L KULCZYCKI
Journal:  AMA J Dis Child       Date:  1958-07

2.  Predictive value of high IgE levels in children.

Authors:  N I Kjellman
Journal:  Acta Paediatr Scand       Date:  1976-07

3.  Serum levels of immune globulins in health and disease: a survey.

Authors:  E R Stiehm; H H Fudenberg
Journal:  Pediatrics       Date:  1966-05       Impact factor: 7.124

4.  Immunological studies in cystic fibrosis.

Authors:  M W Turner; J O Warner; C R Stokes
Journal:  Arch Dis Child       Date:  1978-08       Impact factor: 3.791

5.  The SIgA system and hypersensitivity in patients with cystic fibrosis.

Authors:  J C Wallwork; H McFarlane
Journal:  Clin Allergy       Date:  1976-07

6.  Immediate hypersensitivity in patients with cystic fibrosis.

Authors:  J D Allan; A D Moss; J C Wallwork; H McFarlane
Journal:  Clin Allergy       Date:  1975-09

7.  Circulating soluble immune complexes containing pseudomonas antigens in cystic fibrosis.

Authors:  R W Pitcher-Wilmott; R J Levinsky; D J Matthew
Journal:  Arch Dis Child       Date:  1982-08       Impact factor: 3.791

8.  Bronchial hyperreactivity in cystic fibrosis and asthma.

Authors:  I Mitchell; M Corey; R Woenne; I R Krastins; H Levison
Journal:  J Pediatr       Date:  1978-11       Impact factor: 4.406

9.  Isolation and characterization of circulating immune complexes in cystic fibrosis.

Authors:  R B Moss; Y P Hsu
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

10.  Circulating immune complexes in cystic fibrosis.

Authors:  M Berdischewsky; M Pollack; L S Young; D Chia; A B Osher; E V Barnett
Journal:  Pediatr Res       Date:  1980-06       Impact factor: 3.756

View more
  9 in total

1.  Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection.

Authors:  David Skurnik; Michael R Davis; Dennis Benedetti; Katie L Moravec; Colette Cywes-Bentley; Damien Roux; David C Traficante; Rebecca L Walsh; Tomas Maira-Litràn; Sara K Cassidy; Christina R Hermos; Thomas R Martin; Erin L Thakkallapalli; Sara O Vargas; Alexander J McAdam; Tami D Lieberman; Roy Kishony; John J Lipuma; Gerald B Pier; Joanna B Goldberg; Gregory P Priebe
Journal:  J Infect Dis       Date:  2012-03-23       Impact factor: 5.226

2.  Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis.

Authors:  S S Pedersen; F Espersen; N Høiby; T Jensen
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

3.  Amount and Avidity of IgG Antibodies to Pseudomonas Aeruginosa Exotoxin A Antigen in Cystic Fibrosis Patients.

Authors:  Janja Polanec; Jan Patzer; Jacek Grzybowski; Milan Strukelj; Zlatko P Pavelic
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

Review 4.  Secretory Immunoglobulin A Immunity in Chronic Obstructive Respiratory Diseases.

Authors:  Charlotte de Fays; François M Carlier; Sophie Gohy; Charles Pilette
Journal:  Cells       Date:  2022-04-13       Impact factor: 7.666

5.  Lung involvement, the delta F508 mutation and DNA haplotype analysis in cystic fibrosis.

Authors:  F Santamaria; D Salvatore; O Castiglione; V Raia; G de Ritis; G Sebastio
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

6.  Specific decrease of anti-pseudomonal IgA after anti-pseudomonal therapy in cystic fibrosis.

Authors:  K de Boeck; E Eggermont; M Smet; P van Reempts; H P van Bever; W J Stevens
Journal:  Eur J Pediatr       Date:  1995-02       Impact factor: 3.183

7.  Synthesis and characterization of a Pseudomonas aeruginosa alginate-toxin A conjugate vaccine.

Authors:  S J Cryz; E Fürer; J U Que
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.609

8.  Lung immunoglobulin A immunity dysregulation in cystic fibrosis.

Authors:  Amandine M Collin; Marylène Lecocq; Sabrina Noel; Bruno Detry; François M Carlier; Frank Aboubakar Nana; Caroline Bouzin; Teresinha Leal; Marjorie Vermeersch; Virginia De Rose; Lucile Regard; Clémence Martin; Pierre-Régis Burgel; Delphine Hoton; Stijn Verleden; Antoine Froidure; Charles Pilette; Sophie Gohy
Journal:  EBioMedicine       Date:  2020-09-11       Impact factor: 8.143

Review 9.  Immunoglobulin A Mucosal Immunity and Altered Respiratory Epithelium in Cystic Fibrosis.

Authors:  Sophie Gohy; Alexandra Moeremans; Charles Pilette; Amandine Collin
Journal:  Cells       Date:  2021-12-20       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.